Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test; and Amgen to develop a therapeutic to prevent or treat COVID-19. It serves the life sciences research, clinical diagnostics, and drug discovery customers. Adaptive Biotechnologies Corporation has a translational collaboration with AstraZeneca to investigate the use of immunoSEQ T-MAP. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.

Date	Fund	Action	%
2023/08/22	ARKG	Buy	0.0565
2023/08/21	ARKG	Buy	0.0102
2023/08/18	ARKG	Buy	0.0142
2023/08/17	ARKG	Buy	0.0523
2023/08/16	ARKG	Buy	0.0045
2023/08/15	ARKG	Buy	0.0041
2023/08/14	ARKG	Buy	0.0066
2023/08/03	ARKG	Buy	0.1184
2023/07/17	ARKG	Buy	0.0022
2023/07/14	ARKG	Buy	0.0145
2023/07/11	ARKG	Buy	0.0064
2023/07/10	ARKG	Buy	0.0525
2023/06/06	ARKG	Buy	0.0054
2023/06/05	ARKG	Buy	0.0408
2023/06/02	ARKG	Buy	0.0277
2023/06/01	ARKG	Buy	0.0279
2023/05/31	ARKG	Buy	0.079
2023/05/30	ARKG	Buy	0.0373
2023/05/26	ARKG	Buy	0.0111
2023/05/25	ARKG	Buy	0.1001
2023/05/24	ARKG	Buy	0.0316
2023/05/12	ARKG	Buy	0.0261
2023/05/11	ARKG	Buy	0.1185
2023/05/10	ARKG	Buy	0.0317
2023/05/09	ARKG	Buy	0.0147
2023/05/08	ARKG	Buy	0.034
2023/01/06	ARKG	Buy	0.0341
2023/01/05	ARKG	Buy	0.0026
2023/01/04	ARKG	Buy	0.0022
2023/01/03	ARKG	Buy	0.0141